You have 9 free searches left this month | for more free features.

Small Cell Lung Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • BI 764532
  • [89Zr]Zr-BI 764532
  • (no location specified)
Jul 31, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • BI 764532
  • +5 more
  • (no location specified)
Oct 17, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • (no location specified)
May 25, 2023

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • (no location specified)
Aug 7, 2023

Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Immune signature in serum associated to the metabolic signature
  • Meta-genomic signature of intestinal flora
  • La Tronche, Isère, France
    University Hospital, Grenoble
Jan 6, 2023

Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Self-administered survey at hospital
  • +2 more
  • (no location specified)
Oct 3, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    Extensive Stage Small Cell Lung Cancer

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Aug 6, 2023

      Small Cell Lung Cancer Trial in Cleveland (Alisertib)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Cleveland, Ohio
        Cleveland Clinic
      Oct 18, 2023

      Small Cell Lung Cancer Trial (Tarlatamab)

      Available
      • Small Cell Lung Cancer
      • (no location specified)
      Sep 26, 2023

      EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

      Recruiting
      • EGFR-Mutated Non-Small-Cell Lung Carcinoma
      • Small Cell/Neuroendocrine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

      Not yet recruiting
      • Limited Stage Lung Small Cell Carcinoma
      • +3 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Nov 10, 2023

      Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

      Not yet recruiting
      • Small Cell Lung Carcinoma
      • Neuroendocrine Neoplasms
      • BI 764532
      • (no location specified)
      May 22, 2023

      TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

      Not yet recruiting
      • Lung Cancer, Non-small Cell
      • Small Cell Lung Cancer
        • (no location specified)
        Nov 16, 2022

        Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

        Not yet recruiting
        • Extensive Stage Small Cell Lung Cancer
        • hSTC810 400 mg + Paclitaxel
        • hSTC810 800 mg + Paclitaxel
        • (no location specified)
        Aug 24, 2023

        Participation for Small Cell Lung Cancer Patients

        Not yet recruiting
        • Small Cell Lung Cancer
          • (no location specified)
          Mar 3, 2023

          Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)

          Not yet recruiting
          • Recurrent Extensive Stage Small Cell Lung Carcinoma
          • Hangzhou, China
          • +2 more
          Feb 5, 2023

          Immune-Connected Assays in Small Cell Lung Cancer

          Recruiting
          • Small Cell Lung Cancer
          • Rome, Italy
            Fondazione Policlinico Gemelli IRCCS
          Apr 2, 2023

          Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

          Recruiting
          • Small Cell Lung Cancer
          • Biospecimen Collection
          • Indianapolis, Indiana
          • +1 more
          Jun 2, 2023

          Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

          Not yet recruiting
          • Relapsed Small Cell Lung Cancer
          • Irinotecan hydrochloride liposome Injection
          • Topotecan
          • Beijing, China
            Cancer Hospital, Chinese Academy of Medical Sciences
          Nov 7, 2023

          Proteomics in Small Cell Lung Cancer

          Not yet recruiting
          • Small Cell Lung Cancer
            • (no location specified)
            Nov 14, 2022